rs368773009
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2
The NM_139318.5(KCNH5):c.171C>T(p.Asp57Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000857 in 1,610,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000088 ( 0 hom. )
Consequence
KCNH5
NM_139318.5 synonymous
NM_139318.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.57
Publications
3 publications found
Genes affected
KCNH5 (HGNC:6254): (potassium voltage-gated channel subfamily H member 5) This gene encodes a member of voltage-gated potassium channels. Members of this family have diverse functions, including regulating neurotransmitter and hormone release, cardiac function, and cell volume. This protein is an outward-rectifying, noninactivating channel. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
KCNH5 Gene-Disease associations (from GenCC):
- infantile-onset epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy 112Inheritance: AD Classification: STRONG Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 14-63016857-G-A is Benign according to our data. Variant chr14-63016857-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 416123.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.57 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.0000878 (128/1458528) while in subpopulation NFE AF = 0.000111 (123/1110066). AF 95% confidence interval is 0.0000948. There are 0 homozygotes in GnomAdExome4. There are 69 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAd4 at 10 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNH5 | NM_139318.5 | c.171C>T | p.Asp57Asp | synonymous_variant | Exon 2 of 11 | ENST00000322893.12 | NP_647479.2 | |
| KCNH5 | NM_172375.3 | c.171C>T | p.Asp57Asp | synonymous_variant | Exon 2 of 10 | NP_758963.1 | ||
| KCNH5 | XM_047431275.1 | c.171C>T | p.Asp57Asp | synonymous_variant | Exon 2 of 10 | XP_047287231.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151926Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
10
AN:
151926
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000481 AC: 12AN: 249276 AF XY: 0.0000297 show subpopulations
GnomAD2 exomes
AF:
AC:
12
AN:
249276
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000878 AC: 128AN: 1458528Hom.: 0 Cov.: 30 AF XY: 0.0000951 AC XY: 69AN XY: 725446 show subpopulations
GnomAD4 exome
AF:
AC:
128
AN:
1458528
Hom.:
Cov.:
30
AF XY:
AC XY:
69
AN XY:
725446
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33314
American (AMR)
AF:
AC:
0
AN:
44522
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26002
East Asian (EAS)
AF:
AC:
0
AN:
39586
South Asian (SAS)
AF:
AC:
4
AN:
85750
European-Finnish (FIN)
AF:
AC:
0
AN:
53310
Middle Eastern (MID)
AF:
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
AC:
123
AN:
1110066
Other (OTH)
AF:
AC:
1
AN:
60220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000658 AC: 10AN: 151926Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74208 show subpopulations
GnomAD4 genome
AF:
AC:
10
AN:
151926
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74208
show subpopulations
African (AFR)
AF:
AC:
2
AN:
41388
American (AMR)
AF:
AC:
0
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3464
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10576
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
8
AN:
67940
Other (OTH)
AF:
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.530
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy Benign:1
Nov 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.